Abstract: EAAC1-mediated glutamate transport concentrates glutamate across plasma membranes of brain neurons and epithelia. In brain, EAAC1 provides a presynaptic uptake mechanism to terminate the excitatory action of released glutamate and to keep its extracellular concentration below toxic levels. Here we report the effect of well known anxiolytic compounds, benzodiazepines, on glutamate transport in EAAC1-stably transfected Chinese hamster ovary (CHO) cells and in EAAC1-expressing Xenopus laevis oocytes. Functional properties of EAAC1 agreed well with already reported characteristics of the neuronal high-affinity glutamate transporter (K m D-Asp,CHO cells: 2.23 Ϯ 0.15 M; K m D-Asp,oocytes: 17.01 Ϯ 3.42 M). In both expression systems, low drug concentrations (10 -100 M) activated substrate uptake (up to 200% of control), whereas concentrations in the millimolar range inhibited (up to 50%). Furthermore, the activation was more pronounced at low substrate concentrations (1 M), and the inhibition was attenuated. The activity of other sodium cotransporters such as the sodium/D-glucose cotransporter SGLT1, stably transfected in CHO cells, was not affected by benzodiazepines. In electrophysiological studies, these drugs also failed to change the membrane potential of EAAC1-expressing Xenopus laevis oocytes. These results suggest a direct action on the glutamate transporter itself without modifying the general driving forces. Thus, in vivo low concentrations of benzodiazepines may reduce synaptic glutamate concentrations by increased uptake, providing an additional mechanism to modulate neuronal excitability. Key Words: Glutamate-EAAC1-Transport-Benzodiazepines-Chinese hamster ovary cells-Oocytes.
high-affinity sodium-dependent transporters. So far, five distinct glutamate transporters have been cloned from animal and human tissue: GLAST (EAAT1), GLT-1 (EAAT2), EAAC1 (EAAT3), EAAT4, and EAAT5 (Kanai and Hediger, 1992; Pines et al., 1992; Storck et al., 1992; Kanai et al., 1993; Arriza et al., 1994; Fairman et al., 1995) . They catalyze an electrogenic influx of Lglutamate coupled to sodium symport and potassium antiport (Kanner and Sharon, 1978; Barbour et al., 1988; Zerangue and Kavanaugh, 1996) . Immunohistochemical studies have revealed the following cellular distribution: GLAST and GLT-1 are localized in astrocytes (Rothstein and Kuncl, 1994; Lehre et al., 1995) , EAAC1 is expressed in neurons (Rothstein and Kuncl, 1994) , EAAT4 is present in Purkinje cells (Yamada et al., 1996) , and EAAT5 is found primarily in the human retina (Arriza et al., 1997) .
Because of their prominent role in regulating glutamate levels in the CNS, the transporters have been widely investigated using structural analogues of excitatory amino acids, substrate derivatives, and glutamate receptor agonists or antagonists (Rauen et al., 1992; Arriza et al., 1994; Shimamoto et al., 1998) .
It is generally assumed that neuroleptics produce their antipsychotic actions by a blockade of glutamate action at the receptor level. However, these drugs also have been demonstrated to change the level of glutamate and its metabolism in brain (Michalek et al., 1968; Collins, 1973) . Thus, a direct effect of neuroleptic drugs on glutamate uptake has yet to be tested. Therefore, we have used tracer flux measurements and electrophysiological techniques to assess the effect of benzodiazepines on the neuronal high-affinity glutamate transporter EAAC1.
The present study characterizes the actions of these anxiolytic drugs on EAAC1 expressed in Chinese hamster ovary (CHO) cells and Xenopus laevis oocytes. These experimental systems have the advantage that, in contrast to brain slices or synaptosomal preparations, only one transporter type can be studied in depth. The results presented in the following demonstrate that the neuronal glutamate transporter may also be a target of benzodiazepines in brain.
MATERIALS AND METHODS

Materials
CHO cells were obtained from the American Type Culture Collection (Rockville, MD, U.S.A.). The eukaryotic expression vector pEGFP-C1 was purchased from Clontech (Palo Alto, CA, U.S.A.), restriction enzymes from New England Biolabs (Beverly, MA, U.S.A.), and SuperFect transfection reagent from Qiagen (Hilden, Germany). Tissue culture media and G418 were obtained from GibcoBRL (Eggenstein, Germany). EAAC1 cDNA was kindly provided by Dr. Hediger (Boston, MA, U.S.A.). D-[ 3 H]Aspartic acid (10.5 Ci/mmol) was obtained from DuPont-NEN (Bad Homburg, Germany), and benzodiazepines were from Pharmacia Upjohn (Barcelona, Spain). T7 RNA polymerase was purchased as mMessage mMachine TM T7 Kit (Ambion, Wiesbaden, Germany). All other reagents were of analytical grade.
Stable transfection of a CHO cell line
EAAC1 cDNA was removed from pBluescript SKϩ plasmid by partial digestion with NcoI and total digestion with XbaI. The 3,420 bp of EAAC1 cDNA was then cloned into the expression vector pEGFP-C1, exactly in the region coding for the green fluorescence protein, deleted by digestion with the same enzymes used for pBS-EAAC1, resulting in pEAAC1.
Cells were transfected with branched polycations of a defined spherical shape (SuperFect). Two milligrams of plasmid in 100 l of serum-free medium was mixed with 10 l of SuperFect reagent (3 mg/ml) for 10 min and diluted to 600 l volume.
Thereafter, the medium was replaced by SuperFect reagentfree medium. Two days after transfection, 1 ml of cell suspension was diluted with 15 ml of selection medium [Dulbecco's modified Eagle medium (DMEM), 25 mM D-glucose, 5% fetal calf serum, 1% minimum essential medium, 2 mM L-glutamine, 1 mM sodium pyruvate, 25 M ␤-mercaptoethanol, 1 mM geneticin] in a culture dish (10 cm diameter). For 20 days, culture medium was renewed every 2 days. Subcultures were done by repeated dilution of the cell suspension to select EAAC1-positive clones until reaching one cell per well. DAspartate uptake was measured to select cells for further passages (see below).
Expression of EAAC1 in Xenopus laevis oocytes
EAAC1, cloned in pBluescript SKϩ, was linearized by total digestion with the restriction enzyme BamHI. cDNA template was then transcribed in vitro into cRNA by using T7 polymerase according to its orientation in pBluescript SKϩ.
Oocytes were isolated from Xenopus laevis ovaries by enzymatic digestion for 3 h using gentle agitation in ORII medium (82.5 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 10 mM HEPES/Tris, pH 7.5) containing collagenase type II (2 mg/ml). Thereafter, they were washed with Barth's solution (88 mM NaCl, 1 mM KCl, 10 mM HEPES/Tris, pH 7.5, 0.82 mM Cells were cultured in DMEM on six-well plastic culture plates to 80% confluence. A preincubation time with glutamine-free medium to diminish the intracellular glutamate concentration was not necessary, as D-[ 3 H]aspartate uptake was identical with or without preincubation. Cells were washed three times with 1.5 ml of HEPES-buffered saline (HBS-Na: 137 mM NaCl, 0.7 mM K 2 HPO 4 , 10 mM HEPES, 1 mM MgCl 2 , 1 mM CaCl 2 , 5.5 mM D-glucose, pH 7.4) or HBS-Ch (137 mM choline chloride instead of NaCl) at 37°C and then exposed to 1 ml of transport medium containing 100 M
D-[
3 H]aspartate in sodium buffer or choline buffer for 2 min. D-Aspartate uptake was terminated by removing the transport medium and adding quickly 1.5 ml of ice-cold HBS-Na or HBS-Ch containing 10 mM D-aspartate. Cells were solubilized with 1.5 ml of 2% sodium dodecyl sulfate (SDS) by agitation for 1 h. Samples of 400 l were used for liquid scintillation counting with 7 ml of scintillation fluid or for protein determination following the method described by Lowry et al. (1951) with bovine serum albumin as a standard.
Sodium-dependent transport was calculated as the difference between the radioactivity accumulated by cells incubated with sodium buffer and those incubated with choline buffer.
To examine the effect of benzodiazepines on EAAC1, drugs were added to the transport medium and D-[ 3 H]aspartate uptake was performed as described above. There was no preincubation of the cells with benzodiazepines. Stock solutions of benzodiazepines were prepared in ethanol, and the final concentration of ethanol in the transport media was Ͻ0.1%. At this ethanol concentration, there was no effect on the transport activity.
Sodium/D-glucose cotransport activity was determined by means of ␣-methyl-D-glucoside (AMG) uptake according to the method described by Lin et al. (1998) . In brief, cells were cultured in DMEM in a six-well plastic culture plate to confluence. Before the transport assay, cells were incubated in D-glucose-free culture medium for 1 h at 37°C and then washed twice with Krebs-Ringer-HEPES (KRH)-Na or KRH-choline. After a 15-min incubation of cells in 0.1 mM AMG (containing 0.5 Ci of 14 C-labeled AMG), AMG uptake was terminated by removing the medium and rinsing the cells with ice-cold KRH-Na or KRH-choline containing 0.5 mM phlorizin. Cells were solubilized in 1.5 ml of 2% SDS, and aliquots of 400 l were taken for scintillation counting of radioactive AMG and for protein determination.
EAAC1-expressing Xenopus laevis oocytes. Uptake experiments were done with six to eight oocytes 3 days after injection. After 30 min of incubation in 200 l of uptake medium (100 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 10 mM HEPES/Tris, pH 7.5) with 100 mM D-[ 3 H]aspartate (2 Ci/ml), oocytes were washed three times with the uptake medium containing 100 mM N-methyl-D-glucamine chloride instead of NaCl and then individually lysed with 10% SDS in a scintillation vial. Thereafter, 3 ml of scintillation fluid was added for counting. In sodium-free solutions, 100 mM NaCl was replaced by 100 mM N-methyl-D-glucamine chloride and the pH was adjusted to pH 7.5.
To determine the effect of benzodiazepines on the transport, the compounds were present only during the uptake period.
Electrophysiology
Electrophysiological measurements were done 3-5 days after cRNA injection into Xenopus laevis oocytes by conventional two-microelectrode voltage-clamp techniques. Microelectrodes were pulled from 1.5 mm o.d. (Clark Electromedical Instruments; U.K.) glass capillaries on a Kopf vertical puller (700C; David Kopf Instruments, Tujunga, CA, U.S.A.), were filled with 3 M KCl, and had resistances of 1.5-2.5 M⍀. EAAC1-expressing oocytes were voltage-clamped at Ϫ60 mV and superfused with a modified Ringer's solution (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2 , and 5 mM HEPES, pH 7.5). When dose responses for D-aspartate were measured, this buffer was replaced by one containing the indicated concentration of substrate.
Potential measurements were made on EAAC1-expressing Xenopus laevis oocytes by applying, after stabilization of membrane potential, 100 M D-aspartate or the indicated concentrations of benzodiazepines to the bath medium.
Kinetic and statistical analysis
Kinetic analysis was based on nonlinear regression of uptake velocities versus D-aspartate concentration. Uptake rates were fitted to the following equation:
where V max is the maximum velocity and K m is the substrate concentration required to produce half-maximal velocity.
In voltage-clamp measurements, saturation curves were fitted by least squares to
, where I max is the maximum current generated and K m is the concentration of D-aspartate generating half of the maximum current. Student's t test for nonpaired data and analysis of variance were used to evaluate the statistical significance of differences between individual data points. All data represent means Ϯ SE, and a p level of Յ0.05 was considered to be statistically significant.
RESULTS
Functional expression of EAAC1 in mammalian cells and Xenopus laevis oocytes
D-Aspartate uptake measurements were performed in transfected CHO cells and EAAC1-expressing Xenopus laevis oocytes.
In CHO cells, substrate uptake after stable transfection was increased up to 100-fold at 30 M D-aspartate. The affinity constant, K m , and the maximum velocity of the sodium-dependent uptake, V max , were calculated using the Michaelis-Menten equation. Values of 2.23 Ϯ 0.15 M and 12.12 Ϯ 0.23 nmol/min/mg of protein were obtained (Fig. 1) .
In EAAC1-expressing Xenopus laevis oocytes, substrate-induced current was used as an indicator of uptake. Application of D-aspartate evoked dose-dependent saturable inward currents in cRNA-injected oocytes, but not in water-injected oocytes ( Fig. 2A) . When current amplitudes were plotted against D-aspartate concentrations and fitted with the Michaelis-Menten equation, a K m value of 17.01 Ϯ 3.42 M and I max value of 272.4 Ϯ 7.55 nA were obtained (Fig. 2B) .
Effect of benzodiazepines on EAAC1 activity
A series of 1,4-benzodiazepines were tested for their ability to modify EAAC1 activity in transfected CHO cells and microinjected Xenopus laevis oocytes. The drugs evaluated were medazepam (MZ), oxazepam (OZ), lorazepam (LZ), diazepam (DZ), and the atypical neuroleptic clozapine (CZ; dibenzodiazepine). The chemical formulas are given in Table 1 .
First, the effect of various drugs on D-[ 3 H]aspartate uptake into transfected CHO cells was investigated using 100 M D-aspartate. MZ, OZ, LZ, and DZ activated the transport at low concentrations (10 and 100 M), but inhibited at higher concentrations (1 mM) (Fig. 3) . CZ showed only an inhibitory effect at all concentrations tested. The order of potency for activation was OZ Ͼ DZ Ϸ MZ Ϸ LZ, whereas the order of potency for inhibition was DZ Ϸ LZ Ͼ OZ Ͼ MZ.
To exclude the possibility that benzodiazepines interacted with other proteins intrinsic to CHO cells or modified the membrane potential, the activity of another electrogenic cotransport system, SGLT1, was examined in stably transfected CHO cells (Lin et al., 1998) in the presence of the most potent stimulatory (OZ) and inhibitory (DZ) drugs and the atypical neuroleptic (CZ) (Fig.  4) . OZ and DZ did not affect the sodium-dependent glucose transport rate, suggesting that the glutamate transporter EAAC1 itself is the target of benzodiazepines and not the driving forces for sodium-dependent electrogenic transporters in general. When analyzing the effect of the atypical neuroleptic (CZ) on SGLT1, a slight but significant reduction to 84.7% of the control velocity was observed at the highest drug concentration tested (Fig. 4) .
Potential measurements in EAAC1-expressing Xenopus laevis oocytes were done to address the possibility that benzodiazepines affected the EAAC1 rate due to a change in membrane potential. After stabilization of membrane potential, benzodiazepines were added to the bath solution at the concentrations of 10 M and 1 mM. In these experiments, benzodiazepines failed to change membrane voltage, whereas the application of 100 M D-aspartate, as expected, depolarized the oocyte by 58.7 Ϯ 10.9 mV (n ϭ 5 oocytes) (Fig. 5) .
To examine the mechanism by which benzodiazepines affect the activity of D-aspartate transport, the effect of OZ at two different concentrations of D-aspartate (1 and 100 M) was compared. OZ-mediated activation (10 M) decreased at high aspartate concentrations, whereas OZ-mediated inhibition (1 mM) increased (Fig. 6) .
To study the specificity of the effects observed using D-aspartate, uptake rates were measured in EAAC1-transfected CHO cells at 1 M D-[ 3 H]aspartate and a 100 M concentration of an unrelated amino acid in the presence of 10 M and 1 mM OZ.
The amino acids chosen for these experiments were a neutral and a basic amino acid, L-alanine and L-lysine. The activating effect by 10 M OZ seen at 100 M D-aspartate disappeared when 100 M L-alanine was used instead of 100 M D-aspartate. However, at 1 mM OZ, the inhibitory effect was still present. When Daspartate was substituted by L-lysine, neither the stimulatory nor the inhibitory effect of OZ was observed (Fig. 7) .
Studies of D-[ 3 H]aspartate uptake into injected Xenopus laevis oocytes were also performed using 100 M D-aspartate (2 Ci/ml) at varying benzodiazepine concentrations. Similar to the data obtained in EAAC1-transfected CHO cells, at micromolar concentrations benzodiazepines increased the uptake velocity, and at millimolar concentration an inhibition was observed (Fig. 8) .
In addition, to test whether benzodiazepines were translocated by EAAC1, an electrophysiological analysis was performed on Xenopus laevis oocytes expressing EAAC1. When oocytes were superfused with the drugs, no inward currents were detected, indicating that these compounds are not transported by EAAC1 in an electrogenic step (Fig. 9) . MZ: 7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine; OZ: 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepine-2-one; LZ: 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepine-2-one; DZ: 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepine-2-one; CZ: 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo [b,e] 
FIG. 3. Effect of benzodiazepines on aspartate uptake in EAAC1-transfected CHO cells. D-[
3 H]Aspartate uptake was measured using a fixed concentration of D-aspartate (100 M) and varying drug concentrations (10 M, 100 M, 1 mM). Drugs used were MZ, OZ, LZ, DZ, and CZ. Asterisks denote that the uptake velocity was significantly different (*p Ͻ 0.05, **p Ͻ 0.01) from the control value (n ϭ 3).
DISCUSSION
In the present work, the neuronal high-affinity glutamate transporter, EAAC1, has been expressed in Xenopus laevis oocytes and stably transfected into CHO cells. The stable transfection has provided a more suitable model than the transient expression reported by Arriza et al. (1994) , in which probably different transfection efficiencies led to high variations in the kinetic parameters of transport. The K m values for D-aspartate obtained from stably transfected CHO cells (2.23 Ϯ 0.15 M) and from microinjected oocytes (17.01 Ϯ 3.42 M) are within the range of those found by Kanai and Hediger (1992) . Different K m values, depending on the experimental system and the method used to determine membrane translocations of the substrate (flux studies or electrical measurements), have also been observed by other authors (Dowd et al., 1996; Shimamoto et al., 1998) . As reasons for this discrepancy, differences in the plasma membrane lipid composition or in the posttranslational modification of the transporter have been discussed (Arriza et al., 1997) .
The aim of the present investigations was to characterize the effect of benzodiazepines on a possible presynaptic target in brain, the neuronal high-affinity glutamate transporter (EAAC1). For that purpose, EAAC1 activity was studied in the presence of 1,4-benzodiazepines in the assay systems mentioned before. In both cases, low concentrations of benzodiazepines increased transport, whereas high concentrations inhibited it. Such opposite effects depending on the drug concentration used were also reported by Cauquil-Caubère and Kamenka (1998) in their studies on the effect of hydroxyl radical scavengers on glutamate transport. Some of the compounds tested showed "bell-shaped" dose-response curves.
The authors assumed a protection of glutamate uptake at low concentrations and a disruption of the reuptake function at high concentrations by incorporation of the scavengers into the cellular membrane layer. In our studies, the latter appears not to occur, because the activity of the glucose transporter SGLT1 remained unaltered at high benzodiazepine concentrations.
Stimulation or inhibition can be due to a change in electrochemical gradients. This possibility was tested indirectly by measuring SGLT1 activity and by electrophysiological studies. When the rate of the sodium/Dglucose cotransport was measured under the same experimental conditions as described for D-aspartate uptake, neither the most potent stimulatory drug (OZ) nor the most inhibitory drug (DZ) modified SGLT1 activity. High concentrations of the dibenzodiazepine (CZ) reduced AMG transport; however, this finding does not argue against the specificity of benzodiazepines toward EAAC1. An inhibition by CZ of sodium-independent glucose transport has been reported recently in PC12 cells by Dwyer et al. (1999) in their work on the development of hyperglycemia by antipsychotic drugs.
Potential measurements were done in EAAC1-expressing Xenopus laevis oocytes and ensured that benzodiazepines do not alter the membrane voltage at the concentrations used. Taken together, these data provide evidence that the effects of benzodiazepines are not mediated by other proteins intrinsic in CHO cells or through a change in the electrochemical gradient.
The rapid effects of the benzodiazepines on D-aspartate transport suggest a direct interaction with EAAC1. The possible kinetic mechanism underlying the modulation of transport was investigated by analyzing the effect of OZ at different D-aspartate concentrations. OZ-mediated activation decreased at higher substrate concentrations, whereas OZ-mediated inhibition increased.
According to these results, an interaction of benzodiazepines with the transporter at the substrate transport site cannot be possible. We would rather propose the presence of two different sites for benzodiazepine binding on the glutamate transporter: one stimulatory and the other inhibitory. The difference in relative potency observed, i.e., OZ Ͼ DZ Ϸ MZ Ϸ LZ for stimulation versus DZ Ϸ LZ Ͼ OZ Ͼ MZ for inhibition, supports this assumption.
Furthermore, the stimulatory binding site seems also to bind D-aspartate (but not L-alanine or L-lysine); such an interaction would explain why the degree of stimulation was highest at the lowest D-aspartate concentration tested. The inhibitory binding site seems to be modulated not only by D-aspartate, but also by other amino acids such as L-alanine. However, further experiments are necessary to provide more evidence for these assumptions. Transport studies combined with site-directed mutagenesis might be a way to elucidate the molecular mechanism of benzodiazepine actions.
In vivo, the stimulation of EAAC1 uptake by benzodiazepines at micromolar concentrations suggests an additional mechanism for the anxiolytic effect of these compounds, in agreement with the findings of Hoogerkamp et al. (1996) , who concluded that the effect of benzodiazepines cannot be accounted for only by the interaction at the GABA A -benzodiazepine receptor complex.
Similar to the nicotinic acetylcholine receptors that possess multiple ligand sites (Albuquerque et al., 1997) , the neuronal glutamate transporter appears to be subject to modulatory control by different compounds. In addition, the ability of benzodiazepines to affect EAAC1 activity would suggest the presence of an additional chemical network in the CNS, where a single ligand interacts with different systems . FIG. 9 . Effect of benzodiazepines on membrane currents in EAAC1-expressing Xenopus laevis oocytes. Oocytes were voltage-clamped at Ϫ60 mV and superfused with 1 mM benzodiazepines. The application of these drugs induced no significant currents. In contrast, 100 M D-aspartate induced a large inward current with the same oocytes. Compounds were applied at the time indicated by bars.
